Design of population pharmacokinetic experiments using prior information
- PMID: 17968747
- DOI: 10.1080/00498250701553315
Design of population pharmacokinetic experiments using prior information
Abstract
A population pharmacokinetic study design is a group of elementary designs each composed of a set of sampling times to be performed in a number of subjects in the design. Design factors such as the number of elementary designs, proportion of subjects in each elementary design, number of samples per subject, and sampling times in the subjects need to be carefully balanced in the design of a study. An optimally designed population pharmacokinetic study will give the best combination of these design factors and involves application of statistical experimental design principles to non-linear population pharmacokinetic models. Information from previous experiments, the literature, and experience in the form of model and parameter estimates are used to design a future study by optimization of a design criterion within some constraints. This work provides a brief background of approaches to the designs of a population pharmacokinetic experiment and a review of optimal design methodologies that have been developed for designing population pharmacokinetic experiments. Computer application programs and software that have been developed together with options available in them are also reviewed.
Similar articles
-
A program for the optimum design of pharmacokinetic, pharmacodynamic, drug metabolism and drug-drug interaction models.Comput Methods Programs Biomed. 2005 Jun;78(3):237-49. doi: 10.1016/j.cmpb.2005.02.005. Epub 2005 Apr 22. Comput Methods Programs Biomed. 2005. PMID: 15899308
-
Optimal design of pharmacokinetic studies.Basic Clin Pharmacol Toxicol. 2010 Mar;106(3):250-5. doi: 10.1111/j.1742-7843.2009.00533.x. Epub 2010 Jan 20. Basic Clin Pharmacol Toxicol. 2010. PMID: 20102362 Review.
-
Application of optimal design methodologies in clinical pharmacology experiments.Pharm Stat. 2009 Jul-Sep;8(3):239-52. doi: 10.1002/pst.354. Pharm Stat. 2009. PMID: 19009585 Review.
-
POPED, a software for optimal experiment design in population kinetics.Comput Methods Programs Biomed. 2004 Apr;74(1):29-46. doi: 10.1016/S0169-2607(03)00073-7. Comput Methods Programs Biomed. 2004. PMID: 14992824
-
Development of an optimal sampling strategy for clinical pharmacokinetic studies of the novel anthracycline disaccharide analogue MEN-10755.Cancer Chemother Pharmacol. 2004 Jul;54(1):64-70. doi: 10.1007/s00280-004-0772-7. Epub 2004 Apr 7. Cancer Chemother Pharmacol. 2004. PMID: 15069581 Clinical Trial.
Cited by
-
Development of an optimized dose for coformulation of zidovudine with drugs that select for the K65R mutation using a population pharmacokinetic and enzyme kinetic simulation model.Antimicrob Agents Chemother. 2008 Dec;52(12):4241-50. doi: 10.1128/AAC.00054-08. Epub 2008 Oct 6. Antimicrob Agents Chemother. 2008. PMID: 18838591 Free PMC article.
-
Principles of Experimental Design for Big Data Analysis.Stat Sci. 2017 Aug;32(3):385-404. doi: 10.1214/16-STS604. Stat Sci. 2017. PMID: 28883686 Free PMC article.
-
Application of ED-optimality to screening experiments for analgesic compounds in an experimental model of neuropathic pain.J Pharmacokinet Pharmacodyn. 2012 Dec;39(6):673-81. doi: 10.1007/s10928-012-9278-9. Epub 2012 Nov 30. J Pharmacokinet Pharmacodyn. 2012. PMID: 23197247
-
Fundamentals of Population Pharmacokinetic Modelling : Modelling and Software.Clin Pharmacokinet. 2012 Aug;51(8):515-525. doi: 10.1007/BF03261928. Clin Pharmacokinet. 2012. PMID: 28258394 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources